Risk analysis and long-term survival in patients undergoing resection of T4 lung cancer
Open Access
- 1 August 2001
- journal article
- Published by Oxford University Press (OUP) in European Journal of Cardio-Thoracic Surgery
- Vol. 20 (2) , 344-349
- https://doi.org/10.1016/s1010-7940(01)00788-6
Abstract
Objective: The aim of this study is to identify the risk group of patients with T4 lung cancer who could more likely benefit from surgical resection. Methods: Between January 1, 1990, and December 31, 1998, 77 patients underwent pulmonary resection for T4 lung cancer: lobectomy (n = 20), bilobectomy (n = 4) and pneumonectomy (n = 53). The T4 sites of mediastinal involvement were: Intrapericardiac portions of the pulmonary artery (n = 30), left atrium (n = 19), aorta (n = 8), superior vena cava (n = 8), carina (n = 7), the esophagus (n = 8) and the vertebral body (n = 6). Ten patients had multiple neoplastic nodules in the same lobe of the lung. Results: Overall survival rates at 1, 2 and 3 years were 46, 31 and 21%, respectively. Factors adversely affecting survival with univariate analysis included the localization of tumours in the lower lobe (P=0.04) and both the involvement of superior and inferior mediastinal lymph nodes (P = 0.03). Multivariate analysis included two factors adversely affecting survival: the location of the primary tumour and the nodal stations involved. Regression tree analysis classified the patients into low-risk group (primary tumour in upper lobe or in main stem bronchus and pN0 or pN1 or superior or inferior mediastinal nodes involved), intermediate-risk group (primary tumour in upper lobe or in main stem bronchus and both superior and inferior mediastinal nodes involved, primary tumour in inferior lobe and pN0 or pN1 or inferior mediastinal nodes involved) and high-risk group (primary tumour in inferior lobe and both superior and inferior nodes involved). The 3-year survival rates were 36% for the low-risk group, 4% for the intermediate-risk group and 0% for the high-risk group (P = 0.006). Conclusions: In patients with T4 lung cancer, the surgery can justify itself for tumours in the upper lobe or in the main stem bronchus and with pN0 or pN1.Keywords
This publication has 13 references indexed in Scilit:
- Extended resections for bronchogenic carcinoma invading the superior vena cava systemThe Annals of Thoracic Surgery, 2000
- Preoperative chemoradiotherapy and surgery for selected non-small cell lung cancer IIIB subgroups: long-term resultsThe Annals of Thoracic Surgery, 1999
- Regional Lymph Node Classification for Lung Cancer StagingChest, 1997
- Extended operation for non-small cell lung cancer invading great vessels and left atriumEuropean Journal of Cardio-Thoracic Surgery, 1997
- Risk analysis and long-term survival in patients undergoing extended resection of locally advanced lung cancerThe Journal of Thoracic and Cardiovascular Surgery, 1995
- Management of non-small cell lung cancer with direct mediastinal involvementThe Annals of Thoracic Surgery, 1994
- Extended operations after induction therapy for stage IIIb (T4) non-small cell lung cancerThe Annals of Thoracic Surgery, 1994
- Extended resection of the left atrium, great vessels, or both for lung cancerThe Annals of Thoracic Surgery, 1994
- Limits and perspectives of surgical resection for non-small cell lung cancerLung Cancer, 1991
- Extended intrathoracic resection for lung cancer:Follow-up of 49 CasesScandinavian Journal of Thoracic and Cardiovascular Surgery, 1987